MoneyWorks4Me

Solara Active Pharma Sciences informs about change in KMP

14 Mar 2022 Evaluate

With reference to its earlier communication dated March 9, 2022, wherein the company had mentioned that S. Hariharan's designation as Chief Financial Officer instead of Executive Director and Chief Financial Officer. S. Hariharan is not debarred from holding office of director by virtue of any order by the Securities and Exchange Board of India or any other such authority. The company has attached updated annexure.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1849.00
Dr. Reddys Labs. 1198.85
Cipla 1403.85
Lupin 2085.90
Zydus Lifesciences 1196.00
View more..